非ST段抬高急性冠脉综合征.pptVIP

Berger China 10/0531 SYNERGY Death or MI at 30 Days ? ? 30-Day Death/MI 0.8 1 1.2 Hazard Ratio (95% CI) Enoxaparin Better UFH Better 0 5 10 15 20 25 30 0.8 0.85 0.9 0.95 1.0 F r e e d o m f r o m D e a t h / M I Days from Randomization UFH Enoxaparin HR 0.96 (0.86-1.06) 1.1 Berger China 10/0532 SYNERGY Bleeding Events Enoxaparin UFH (n = 4993) (n = 4985) P-value GUSTO severe 2.9 2.4 0.107 TIMI major - clinical: 9.1 7.6 0.008 CABG-related 6.8 5.9 0.081 Non-CABG-related 2.4 1.7 0.025 Any RBC transfusi